Rhizome AI Analysis
What is Rhizome AI?
Rhizome AI builds an AI research tool for regulatory intelligence in life sciences. The product answers questions with cited sources from FDA, EMA, and related health authority databases, including up to 1,000 supporting documents per answer. The company says dozens of organizations use Rhizome Ask for regulatory strategy, clinical trial design, and product development questions.
Location
Jersey City, New Jersey, United States
Employees
1-10
Founded
2025
Business Model v4
AI-enhanced software
Delivery Model
Self-serve SaaS / software
Functional Type
Compliance Tech,HR Software,Other
YC Batch
W26
YC Partner
Tyler Bosmeny
Product Features & Capabilities
- Regulatory insights platform
- Access to FDA and EMA datasets
- Document verification tools
- Demo scheduling for product exploration
Use Cases
Answer regulatory questions using 1,000+ documents; Verify sources for regulatory compliance; Research FDA-approved mouthwashes; Access clinical trial data; Monitor regulatory updates across multiple markets
Who are the founders of Rhizome AI
CM
Chetan Mishra
Founder
Product Description
Rhizome AI offers a regulatory insights platform that provides instant access to regulatory information from FDA and EMA databases. This platform enables users, particularly regulatory affairs professionals in pharmaceuticals and compliance officers in healthcare, to efficiently answer complex regulatory questions.
Key features of Rhizome AI's offerings include:
- Comprehensive Research: The platform aggregates data from 26 regulatory and clinical databases across six markets, ensuring users have access to the most current information available.
- Document Verification Tools: Users can cite up to 1,000 documents from these datasets, enhancing the reliability of their research.
- User-Friendly Interface: The platform is designed to facilitate easy navigation and quick access to necessary information.
The benefits of using Rhizome AI include improved efficiency in regulatory research, reduced time spent on information gathering, and enhanced accuracy in compliance-related tasks.
Other Considerations
Serves large pharma and independent consultants; Data refreshed in line with regulatory updates; Positive testimonials from industry professionals
See something that needs updating? Suggest edits to this profile.